Horizon Therapeutics plc Named One of the Most Innovative Companies by Crain’s Chicago Business
October 24 2019 - 11:15AM
Business Wire
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it
is has been named one of the Most Innovative Companies in Chicago
by Crain’s Chicago Business, ranking number two. Crain’s compiles
the list based on a review by independent intellectual property
valuation firm, Ocean Tomo, which evaluates companies that were
awarded at least five patents last year.
Horizon made this year’s list based on its work with its
medicine used to treat urea cycle disorders (UCD), a rare genetic
disorder that affects approximately 1 in 35,000 live births in the
United States.
“At Horizon, we place special emphasis on innovation where we
apply scientific expertise to address the most challenging needs
patients face,” said Timothy Walbert, chairman, president and chief
executive officer, Horizon. “We are honored to be recognized by
Crain’s for our efforts and will continue to move decisively
through the clinical process, to bring new and novel therapies to
patients, their families and those who care for them.”
About Crain’s Chicago Business
For 40 years, Crain’s Chicago Business has been a top source of
news, analysis and information on business in metropolitan Chicago
for decision-makers in the private and public sectors. More than a
collection of products, Crain’s Chicago Business is a rich media
environment—in print, online, mobile, video, live events and
executive training.
About Horizon
Horizon is focused on researching, developing and
commercializing medicines that address critical needs for people
impacted by rare and rheumatic diseases. Our pipeline is
purposeful: we apply scientific expertise and courage to bring
clinically meaningful therapies to patients. We believe science and
compassion must work together to transform lives. For more
information on how we go to incredible lengths to impact lives,
please visit www.horizontherapeutics.com, follow us @HorizonNews on
Twitter, like us on Facebook or explore career opportunities on
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191024005651/en/
U.S. Media Contact: Geoff Curtis Executive Vice
President, Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com Ireland Media: Ray Gordon
Gordon MRM ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Apr 2023 to Apr 2024